Showing results (121-130 of 769) with videos related to
Sort By:
Pageof 77
Schizophrenia Research|November 25, 2020
Cognitive decline and impairment in schizophrenia spectrum disorders reconsideredMelissa E Parlar, R Walter HeinrichsJournal - Association of Official Analytical Chemists|May 1, 1987
Regression analysis of use-dilution disinfectant test data as an alternative to current registration practicesG R Walter, J R TroutClinical Diabetes : a Publication of the American Diabetes Association|November 17, 2022
Factors Associated With Improved A1C Values Among People With Uncontrolled Type 2 DiabetesShannon R Walter, Ryan A PoppAmerican Journal of Obstetrics and Gynecology|May 20, 2024
Consumer wearables and personal devices for tracking the fertile windowSarah C Cromack, Jessica R WalterBrain Research|June 26, 2007
Expression of APP pathway mRNAs and proteins in Alzheimer's diseaseToshifumi Matsui, Martin Ingelsson, Hiroaki Fukumoto, et al.Neuroscience Letters|October 16, 2007
The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's diseaseVilmantas Giedraitis, Johan Sundelöf, Michael C Irizarry, et al.Brain Research. Molecular Brain Research|July 16, 2002
LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytesKatrin Arélin, Ayae Kinoshita, Christa M Whelan, et al.Journal of Neuropathology and Experimental Neurology|May 26, 1998
Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivityM C Irizarry, W Growdon, T Gomez-Isla, et al.The Journal of Prevention of Alzheimer'S Disease|March 14, 2026
Discordance in amyloid positivity between visual reads and Centiloids: Impact of white matter uptakeArnaud Charil, Todd M Nelson, Anthonin Reilhac, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSteven Hersch, Michelle Gee, Thomas Doherty, et al.Pageof 77